BACKGROUND: The reduction in cervical cancer mortality in developed countries has been attributed to well-organized, population-based prevention and control programs that incorporate screening with the Papanicolaou (Pap) smear. In Mexico, there has been a decrease in cervical cancer mortality, but it is unclear what factors have prompted this reduction. METHODS: Using data from national indicators, we determined the correlation between cervical cancer mortality rates and Pap coverage, birthrate, and gross national product, using a linear regression model. We determined relative risk of dying of cervical cancer according to place of residence (rural/urban, region) using a Poisson model. We also estimated Pap smear coverage using national survey data and evaluated the validity and reproducibility of Pap smear diagnosis. RESULTS: An increase in Pap coverage (beta= -0.069) and a decrease in birthrate (beta=0.054) correlate with decreasing cervical cancer mortality in Mexico. Self-reported Pap smear rates in the last 12 months vary from 27.4% to 48.1%. Women who live in the central (relative risk, 1.04) and especially the southern (relative risk, 1.47) parts of Mexico have a greater relative risk of dying of cervical cancer than those who live in the north. There is a high incidence of false negatives in cervical cytology laboratories in Mexico; the percentage of false negatives varies from 3.33% to 53.13%. CONCLUSIONS: The decrease in cervical cancer mortality observed in Mexico is proportional to increasing Pap coverage and decreasing birthrate. Accreditation of cervical cytology laboratories is needed to improve diagnostic precision.
BACKGROUND: The reduction in cervical cancer mortality in developed countries has been attributed to well-organized, population-based prevention and control programs that incorporate screening with the Papanicolaou (Pap) smear. In Mexico, there has been a decrease in cervical cancer mortality, but it is unclear what factors have prompted this reduction. METHODS: Using data from national indicators, we determined the correlation between cervical cancer mortality rates and Pap coverage, birthrate, and gross national product, using a linear regression model. We determined relative risk of dying of cervical cancer according to place of residence (rural/urban, region) using a Poisson model. We also estimated Pap smear coverage using national survey data and evaluated the validity and reproducibility of Pap smear diagnosis. RESULTS: An increase in Pap coverage (beta= -0.069) and a decrease in birthrate (beta=0.054) correlate with decreasing cervical cancer mortality in Mexico. Self-reported Pap smear rates in the last 12 months vary from 27.4% to 48.1%. Women who live in the central (relative risk, 1.04) and especially the southern (relative risk, 1.47) parts of Mexico have a greater relative risk of dying of cervical cancer than those who live in the north. There is a high incidence of false negatives in cervical cytology laboratories in Mexico; the percentage of false negatives varies from 3.33% to 53.13%. CONCLUSIONS: The decrease in cervical cancer mortality observed in Mexico is proportional to increasing Pap coverage and decreasing birthrate. Accreditation of cervical cytology laboratories is needed to improve diagnostic precision.
Authors: Claire C Bristow; Brandon Brown; Logan Marg; Raquel I Iñiguez; Kristen Meckel-Parker; Jay G Silverman; Carlos Magis-Rodriguez; Tommi L Gaines; Kimberly C Brouwer Journal: Int J STD AIDS Date: 2019-06-03 Impact factor: 1.359
Authors: Dyanne G Herrera; Emily L Schiefelbein; Ruben Smith; Rosalba Rojas; Gita G Mirchandani; Jill A McDonald Journal: Matern Child Health J Date: 2012-12
Authors: Ana P Martínez-Donate; Lina M Vera-Cala; Xiao Zhang; Rhea Vedro; Rosario Angulo; Tanya Atkinson Journal: J Health Care Poor Underserved Date: 2013-11
Authors: Yvonne N Flores; David M Bishai; Attila Lorincz; Keerti V Shah; Eduardo Lazcano-Ponce; Mauricio Hernández; Víctor Granados-García; Ruth Pérez; Jorge Salmerón Journal: Cancer Causes Control Date: 2010-12-18 Impact factor: 2.506
Authors: Mariano Guardado-Estrada; Eligia Juárez-Torres; Edgar Román-Bassaure; Ingrid Medina-Martinez; Ana Alfaro; Rosa Elba Benuto; Michael Dean; Nicolás Villegas-Sepulveda; Jaime Berumen Journal: PLoS One Date: 2014-10-08 Impact factor: 3.240
Authors: Fábio Marques de Almeida; José Carlos de Oliveira; Edésio Martins; Maria Paula Curado; Ruffo de Freitas; Marise Amaral Rebouças Moreira Journal: BMC Public Health Date: 2013-06-09 Impact factor: 3.295
Authors: Mónica Terán-Hernández; Rebeca Ramis-Prieto; Jaqueline Calderón-Hernández; Carlos Félix Garrocho-Rangel; Juan Campos-Alanís; José Antonio Ávalos-Lozano; Miguel Aguilar-Robledo Journal: Int J Equity Health Date: 2016-09-29